Patent · US Active

c-fms kinase inhibitors

US7790724B2 · kind B2 · utility

19Cited by

22References

9Claims

0Family size

Assignee

Janssen Pharmaceutica NA · BE

Inventors

Mark R. Player · Phoenixville, US
Nand Baindur · Kendall Park, US
Benjamin Brandt · Philadelphia, US
Naresh Chadha · Nutley, US
Raymond J. Patch · Yardley, US
Davoud Asgari · Wilmington, US
Taxiarchis Georgiadis · Carmel, US

Key dates

Filing date	Apr 20, 2006
Grant date	Sep 7, 2010
Priority date	—
Expiry date	Jun 12, 2029

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D409/12
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention is directed to compounds of Formula II:wherein A, R1, R2, R3, R4, X, Y and W are set forth in the specification, as well as solvates, hydrates, tautomers or pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.